Vitamin D Serum Levels and the Development of Intensive Care Unit-Acquired Weakness: Insights from a COVID-19 Intensive Care Cohort
Abstract
Share and Cite
Gulišija, J.; Čapkun, V.; Golic, S.; Stojanović Stipić, S. Vitamin D Serum Levels and the Development of Intensive Care Unit-Acquired Weakness: Insights from a COVID-19 Intensive Care Cohort. Pathophysiology 2025, 32, 21. https://doi.org/10.3390/pathophysiology32020021
Gulišija J, Čapkun V, Golic S, Stojanović Stipić S. Vitamin D Serum Levels and the Development of Intensive Care Unit-Acquired Weakness: Insights from a COVID-19 Intensive Care Cohort. Pathophysiology. 2025; 32(2):21. https://doi.org/10.3390/pathophysiology32020021
Chicago/Turabian StyleGulišija, Jelena, Vesna Čapkun, Stefan Golic, and Sanda Stojanović Stipić. 2025. "Vitamin D Serum Levels and the Development of Intensive Care Unit-Acquired Weakness: Insights from a COVID-19 Intensive Care Cohort" Pathophysiology 32, no. 2: 21. https://doi.org/10.3390/pathophysiology32020021
APA StyleGulišija, J., Čapkun, V., Golic, S., & Stojanović Stipić, S. (2025). Vitamin D Serum Levels and the Development of Intensive Care Unit-Acquired Weakness: Insights from a COVID-19 Intensive Care Cohort. Pathophysiology, 32(2), 21. https://doi.org/10.3390/pathophysiology32020021